Healthcare Sales & Marketing Network News: genomics

Searching News Database: genomics

HSMN NewsFeed - 20 Nov 2025
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 10 Nov 2025
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review
Diagnostics Personnel

HSMN NewsFeed - 11 Sep 2025
Laborie Appoints Chris Smith as Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 6 Mar 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch

HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 28 Mar 2024
Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 29 Sep 2023
nRichDX Launches New CTC Enrichment Kit
Diagnostics Oncology Product Launch

HSMN NewsFeed - 16 May 2023
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Biopharmaceuticals

HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel

HSMN NewsFeed - 16 Nov 2022
Haystack Oncology Launches with $56 Million in Series A Financing to Accelerate Adoption of Post-Op Cancer Detection Technology and Optimize Cancer Therapy Monitoring and Treatment
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 5 Oct 2022
Cellecta, Inc. Launches DriverMap(TM) Adaptive Immune Receptor (AIR) TCR and BCR Kits for Comprehensive Immune Repertoire Profiling
Diagnostics Product Launch

HSMN NewsFeed - 21 Sep 2022
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Aug 2022
Plexium Strengthens Leadership Team with Appointment of Daniel Sipes as Senior Vice President, Head of Technology
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jul 2022
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 May 2022
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 9 Feb 2022
Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix(TM) Product Platform
Devices Orthopaedic Venture Capital

HSMN NewsFeed - 28 Oct 2021
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Diagnostics Personnel

HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Jun 2021
Eisai Inc. Announces the Appointment of Dr. Andree Amelsberg as Vice President, U.S. Medical Affairs, Oncology Business Group
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 May 2021
Rigel Appoints Alison L. Hannah, M.D. to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions

HSMN NewsFeed - 19 Apr 2021
Amgen Launches Biomarker Assist(TM), a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing
Diagnostics Oncology Product Launch

HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Nov 2020
Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research
Diagnostics Product Launch

HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 26 Oct 2020
Helix Receives Expanded Emergency Use Authorization for On-site Unsupervised Self-Collection and Asymptomatic Screening with the Helix(R) COVID-19 Test
Diagnostics FDA

HSMN NewsFeed - 25 Sep 2020
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients
Diagnostics

HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
Diagnostics Neurology

HSMN NewsFeed - 11 Aug 2020
Wouter Meuleman Promoted to Partner of Illumina Ventures
Biopharmaceuticals Diagnostics Venture Capital Personnel

HSMN NewsFeed - 7 Aug 2020
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 7 Jul 2020
Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Diagnostics Oncology

HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 16 Jun 2020
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Jun 2020
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 May 2020
Cardiff Oncology Announces Fast Track Designation Granted by the FDA to Onvansertib for Second-Line Treatment of KRAS-Mutated Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 May 2020
New Oncotype DX(R) Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results
Diagnostics Oncology

HSMN NewsFeed - 15 Apr 2020
Mesa Biotech Announces Ingo Chakravarty as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Apr 2020
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Apr 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 24 Feb 2020
Dovetail Genomics Introduces New Dovetail(TM) Micro-C and HiChIP Kits
Diagnostics Product Launch

HSMN NewsFeed - 24 Feb 2020
Karius Secures $165 Million In Series B Funding Led By SoftBank Vision Fund 2
Diagnostics Venture Capital

HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel

HSMN NewsFeed - 11 Feb 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2019
Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Dec 2019
Encoded Therapeutics Strengthens Senior Leadership Team with Key Appointments in Regulatory and Human Resources Functions
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2019
IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 17 Oct 2019
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Oct 2019
Paragon Genomics Introduces New CleanPlex(R) Hereditary Cancer Panel V2 At American Society For Human Genetics 2019 Annual Meeting
Diagnostics Oncology Product Launch

HSMN NewsFeed - 11 Oct 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
Diagnostics Reimbursement

HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Aug 2019
Richard Creager Joins Ubiquitome Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Jun 2019
Genome Medical Raises $23 Million in Series B Financing to Advance the Adoption of Genomics in Everyday Medical Care
Diagnostics Venture Capital

HSMN NewsFeed - 8 May 2019
Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Apr 2019
Arc Bio Unveils its Galileo(TM) Pathogen Solution: A Fully Integrated NGS-based Metagenomics Platform with a Revolutionized Design for Pathogen Detection
Diagnostics Product Launch

HSMN NewsFeed - 7 Jan 2019
Lilly Announces Agreement To Acquire Loxo Oncology
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2019
Clinical Genomics Appoints Betsy Hanna CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 16 Oct 2018
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2018
Paragon Genomics Introduces CleanPlex(R) UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
Diagnostics Oncology Product Launch

HSMN NewsFeed - 3 Oct 2018
Trovagene Announces Exclusive License Agreement with MIT for Combination Therapy of Anti-Androgens and Polo-like Kinase Inhibitors in Prostate Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 29 Aug 2018
Trovagene Announces European Commission Grants Orphan Drug Designation to Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Diagnostics

HSMN NewsFeed - 24 Jul 2018
GenomeDx Announces Medicare Draft Local Coverage Determination (LCD) for Decipher Prostate Biopsy Genomic Classifier
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Jun 2018
Caris Life Sciences Expands Management Team
Diagnostics Personnel

HSMN NewsFeed - 22 Jun 2018
William A. Haseltine, PhD Joins Grace Therapeutics' Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Diagnostics Oncology Product Launch

HSMN NewsFeed - 13 Jun 2018
Akonni Biosystems Announces the Appointment of Lawrence Firestone as Executive Vice President and Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel

HSMN NewsFeed - 9 Apr 2018
Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 27 Mar 2018
Singlera Genomics Raises $60 Million in Series A+ Financing
Diagnostics Venture Capital

HSMN NewsFeed - 21 Mar 2018
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Biopharmaceuticals Personalized Medicine Licensing

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Feb 2018
Metabolon Launches Meta UDx(TM) Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and Adults
Diagnostics Product Launch

HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
Diagnostics Oncology

HSMN NewsFeed - 20 Feb 2018
Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Jan 2018
Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jan 2018
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 16 Jan 2018
Sequence Bio appoints Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery projects
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2018
Genome Medical Launches Genetic Health Programs for Employer Groups
Diagnostics Product Launch

HSMN NewsFeed - 5 Jan 2018
Genome Medical Expands Financing with Strategic Investments by GE Ventures, Kaiser Permanente Ventures and Illumina Ventures
Diagnostics Venture Capital

HSMN NewsFeed - 4 Jan 2018
AOBiome Therapeutics Appoints Todd Krueger as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2018
Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel

HSMN NewsFeed - 1 Dec 2017
Bayer and the Broad Institute of MIT and Harvard Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Nov 2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
Devices Interventional Acquisitions

HSMN NewsFeed - 16 Oct 2017
Illumina Ventures Closes $230 Million Fund
Biopharmaceuticals Personalized Medicine Venture Capital

HSMN NewsFeed - 25 Sep 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Biopharmaceuticals Personalized Medicine Oncology

HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2017
Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Sep 2017
Myriad Genetics Announces Positive Data Supporting New riskScore(TM) Test at the 36th Annual Conference of the National Society of Genetic Counselors
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 11 Sep 2017
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital

HSMN NewsFeed - 10 Aug 2017
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jul 2017
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Devices Diagnostics FDA

HSMN NewsFeed - 18 Jul 2017
BD Transforms Microbiology Urine Testing
Diagnostics Product Launch

HSMN NewsFeed - 30 Jun 2017
BioMarin Submits Pegvaliase Biologics License Application (BLA) to the U.S. FDA for Treatment of Phenylketonuria (PKU)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jun 2017
Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe
Diagnostics Product Launch

HSMN NewsFeed - 20 Jun 2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
Devices Surgery FDA

HSMN NewsFeed - 15 Jun 2017
Magstim Group, Inc. Appoints Lothar Krinke as New CEO
Devices Neurology Personnel

HSMN NewsFeed - 5 Jun 2017
BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea
Diagnostics FDA

HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 16 May 2017
Thermo Fisher Scientific's One Lambda Brand Signs Exclusive Licensing Agreement with Transcriptome Sciences Inc. for access to Molecular Microscope Diagnostic System
Diagnostics Oncology Licensing

HSMN NewsFeed - 9 May 2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
Devices Surgery

HSMN NewsFeed - 26 Apr 2017
BD Licenses Novel Molecular Indexing Technology to Roche
Diagnostics Licensing

HSMN NewsFeed - 24 Apr 2017
BD Announces Appointment Of Tom Polen As President
Devices Personnel

HSMN NewsFeed - 24 Apr 2017
BD to Acquire Bard for $24 Billion
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Mar 2017
Vencerx Therapeutics Announces Appointments of Robert H. Ring, Ph.D. as Chief Executive Officer and Jeffrey Stevenson as Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 28 Mar 2017
Personal Genome Diagnostics' Expanded PlasmaSELECT(TM) 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology
Diagnostics Oncology Product Launch

HSMN NewsFeed - 16 Mar 2017
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation
Regenerative Medicine Venture Capital

HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
Diagnostics FDA

HSMN NewsFeed - 9 Feb 2017
Syndax Appoints Richard P. Shea as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 1 Feb 2017
Marinus Appoints Michael R. Dougherty to its Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Diagnostics Personnel

HSMN NewsFeed - 23 Jan 2017
PleurX(TM) Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
Devices FDA

HSMN NewsFeed - 17 Jan 2017
Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development
Diagnostics Oncology Personalized Medicine Personnel

HSMN NewsFeed - 3 Jan 2017
Agios Appoints Ian Clark to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Dec 2016
Dovetail Genomics Signs Japan Distribution Agreement
Diagnostics Distribution

HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 30 Nov 2016
Novogene Completes USD $75 Million B Round Financing
Diagnostics Venture Capital

HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
Devices Drug Delivery Endocrinology Product Launch

HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine

HSMN NewsFeed - 31 Oct 2016
BD MAX(TM) Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Diagnostics FDA

HSMN NewsFeed - 25 Oct 2016
Agilent Technologies Receives Expanded FDA Approval for Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Non-Small Cell Lung Cancer (NSCLC)
Diagnostics Oncology FDA

HSMN NewsFeed - 24 Oct 2016
Personal Genome Diagnostics Launches RNAcomplete(TM) Allowing Co-Extraction and Analysis of RNA and DNA from a Single FFPE Tissue Sample
Diagnostics Oncology Product Launch

HSMN NewsFeed - 20 Oct 2016
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 9 Sep 2016
Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
Diagnostics FDA

HSMN NewsFeed - 22 Aug 2016
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 26 Jul 2016
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 19 Jul 2016
Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products
Diagnostics Product Launch

HSMN NewsFeed - 8 Jun 2016
Personal Genome Diagnostics Names Abigail McElhinny Senior Vice President of Research & Development, Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 25 May 2016
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 19 May 2016
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy
Diagnostics Devices Oncology

HSMN NewsFeed - 13 May 2016
WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 6 May 2016
ACT Genomics Raises $12.5 Million In Series B Funding
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 21 Apr 2016
BD Divests Vertebral Augmentation Solutions Business to Stryker
Devices Orthopaedic Neurosurgery Acquisitions

HSMN NewsFeed - 20 Apr 2016
Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 3 Mar 2016
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
Devices Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 18 Feb 2016
Philips and Hitachi Data Systems to Deliver Next-Generation Data Management Solution for Healthcare Organization-Wide Access to Billions of Medical Images
Devices Radiology

HSMN NewsFeed - 17 Feb 2016
BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience
Devices FDA

HSMN NewsFeed - 12 Feb 2016
MedGenome Announces $10 Million Commitment to GenomeAsia 100K to Sequence 100,000 Genomes in South Asia
Diagnostics

HSMN NewsFeed - 10 Feb 2016
BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS
Devices Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 8 Feb 2016
Rubicon Genomics Announces Distribution Agreement with Beckman Coulter Life Sciences for its ThruPLEX(R) Plasma-Seq Kits
Diagnostics Distribution

HSMN NewsFeed - 3 Feb 2016
LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 26 Jan 2016
Inivata Completes £31.5 Million ($45M) Series A Fundraising Round
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel

HSMN NewsFeed - 7 Jan 2016
Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing(TM) Platform in Oncology
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 15 Dec 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Diagnostics Oncology Venture Capital Personnel

HSMN NewsFeed - 21 Oct 2015
NeoGenomics signs Definitive Agreement to acquire Clarient, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Sep 2015
David Kaysen Named President & CEO of Sun BioPharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jul 2015
Castle Biosciences Closes $11.7 Million Tranche of $20 Million Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 6 Jul 2015
Darin Leigh Joins Metabolon as Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 1 Jul 2015
Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Jun 2015
Personal Genome Diagnostics Launches LungSelect(TM) For Non-Invasive Detection Of Clinically Actionable Mutations In Lung Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 11 May 2015
PaxVax Appoints Nima Farzan Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Apr 2015
NeoGenomics Announces Promotions
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Mar 2015
Pathway Genomics Appoints Former Cedars-Sinai Chair of Medicine Glenn D. Braunstein, M.D., as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 2 Mar 2015
Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer
Devices Drug Delivery Venture Capital Personnel

HSMN NewsFeed - 23 Feb 2015
Compugen Expands and Strengthens Business Development Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Diagnostics Personnel

HSMN NewsFeed - 3 Feb 2015
Guardant Health Secures Additional $50 Million Based On Strong Demand For Its Biopsy-Free Cancer Blood Test, Guardant360(R)
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 9 Jan 2015
bioTheranostics Appoints Key Executives to Leadership Team
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 12 Nov 2014
Blueprint Medicines Secures $50 Million in Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Sep 2014
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Aug 2014
Rosetta Genomics Expands Management Team With Appointment of Douglas Sites as Executive Vice President of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 17 Jul 2014
Edico Genome Raises $10 Million in Series A Financing to Commercialize DRAGEN Chip to Overcome Sequencing Data Analysis Bottleneck
Devices Diagnostics Venture Capital

HSMN NewsFeed - 16 Jul 2014
Virobay Completes $8 Million Series B Preferred Stock Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Jul 2014
MYOS Corporation Appoints World Renowned Scientific Visionary and Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 16 Jun 2014
Agena Bioscience Announces FDA 510(k) Premarket Clearance of the IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test on the IMPACT Dx(TM) System
Diagnostics FDA

HSMN NewsFeed - 9 Jun 2014
Rubicon Genomics Adds European Distributors Ahead Of New Product Launches
Diagnostics Distribution

HSMN NewsFeed - 30 May 2014
Guardant Health Announces US Commercial Launch of Guardant360(TM): A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management
Diagnostics Oncology Product Launch

HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2014
Beryllium Launches and Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2014
Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2014
23andMe Appoints Dr. Jill Hagenkord Chief Medical Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 1 Apr 2014
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 18 Mar 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
Diagnostics Oncology Product Launch

HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics

HSMN NewsFeed - 4 Mar 2014
Contextual Genomics Appoints Chris Wagner as President & CEO
Diagnostics Oncology Cardiology Personnel

HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Diagnostics Oncology Reimbursement Personnel

HSMN NewsFeed - 7 Feb 2014
BRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit
Diagnostics Oncology Litigation

HSMN NewsFeed - 6 Feb 2014
Pathway Genomics Names Ardy Arianpour as Chief Strategy Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 3 Jan 2014
DNAnexus Secures $15 Million in Series C Financing to Accelerate Commercialization of Its Enterprise Platform for DNA Sequencing Data
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 20 Dec 2013
Natera Names Susan Gross, M.D., Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Diagnostics Personalized Medicine

HSMN NewsFeed - 2 Dec 2013
Personalized Cancer Therapy, Inc. (Perthera) Launches to Provide New Hope for Fighting Advanced-Stage Cancers
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 7 Nov 2013
Pathway Genomics Names Robert C. Verfurth as Vice President of Sales
Diagnostics Personnel

HSMN NewsFeed - 28 Oct 2013
Lorus Therapeutics Appoints New Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Oct 2013
Immune Pharmaceuticals Announces Changes to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2013
Molecular Templates Announces $8.5M Series C Financing and $10.6M Grant Funding
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 7 Oct 2013
Personalis Closes $22M Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology

HSMN NewsFeed - 9 Sep 2013
Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 3 Sep 2013
Champions Oncology Announces Two Additions to Senior Management Team
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 7 Aug 2013
Gene by Gene Acquires Arpeggi, a StartUp Health- and GE-Backed Company, to Build World's Leading Genetic Testing and Genome Diagnostics Company
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2013
Affymetrix Launches New OncoScan(TM) FFPE Assay Kit
Diagnostics Oncology Product Launch

HSMN NewsFeed - 26 Jul 2013
Meditope Biosciences Raises $3.6M in Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Jul 2013
GeneNews Announces Management and Board Changes
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory

HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 10 Jan 2013
Pathway Genomics Names Todd G. Johnson as Vice President of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 20 Dec 2012
Venaxis Board Appoints Senior Diagnostics Executive to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 5 Nov 2012
Pathwork Diagnostics Inc. Appoints Lee McCracken as CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Diagnostics Oncology Personalized Medicine Personnel

HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 20 Sep 2012
Foundation Medicine Announces $42.5 Million Series B Financing
Personalized Medicine Oncology Venture Capital

HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Personalized Medicine Cardiology Venture Capital

HSMN NewsFeed - 18 Jul 2012
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE(TM) Cancer Profile Panels
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 30 May 2012
AssureRx Health Raises $12.5 Million Series C Financing
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 19 Apr 2012
EnVivo Pharmaceuticals Names Christopher L. Burnley Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2012
Mayo Clinic Breast Cancer Study Finds New Type of Mutation
Diagnostics Oncology

HSMN NewsFeed - 14 Mar 2012
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 9 Feb 2012
PaxVax Expands Executive Management Team
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 27 Jan 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2011
Interleukin Genetics Appoints Lynn Doucette-Stamm Vice President of Development
Diagnostics Personnel

HSMN NewsFeed - 1 Nov 2011
H3 Biomedicine Names Markus Warmuth Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Oct 2011
Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 1 Aug 2011
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2011
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
Diagnostics Personnel

HSMN NewsFeed - 13 Jun 2011
Cytochroma Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Apr 2011
Rosetta Genomics Names Brian Markison Board Chairman
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 11 Apr 2011
Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments
Personalized Medicine Oncology Venture Capital

HSMN NewsFeed - 7 Apr 2011
MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
Personalized Medicine Personnel Venture Capital

HSMN NewsFeed - 14 Mar 2011
Mira Dx(TM) Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges”
Diagnostics Oncology

HSMN NewsFeed - 10 Mar 2011
Agendia Hires David Macdonald as Chief Operating Officer, Mark Willig as Executive VP of North American Sales, and Doug Bradley as Vice President of Global Marketing
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 16 Feb 2011
Mitomics Further Strengthens Leadership Team
Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Jan 2011
SwitchGear Genomics Announces Distribution Agreement For FuGENE(R) HD Transfection Reagent and Novel Transfection Optimization Kit
Diagnostics Distribution

HSMN NewsFeed - 7 Jan 2011
23andMe Announces Additional Investment in Series C Financing; Dr. Ashley Ledbetter Dombkowski of MPM Capital Joins 23andMe's Board of Directors
Personalized Medicine Venture Capital Personnel

HSMN NewsFeed - 6 Jan 2011
Saladax Biomedical Appoints Edward L. Erickson as President and CEO
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2011
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2010
Brian Markison to Join Rosetta Genomics Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 26 Oct 2010
AspenBio Advances AppyScore(TM) Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise
Diagnostics Personnel

HSMN NewsFeed - 7 Oct 2010
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2010
Positive Reimbursement Coverage Issued for RedPath's PathFinderTG(R) Technology
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Aug 2010
Radient Pharmaceuticals Appoints Gary Giarratano as Director of North American Sales and Marketing
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Mar 2010
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics

HSMN NewsFeed - 24 Feb 2010
Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
Personalized Medicine Diagnostics Litigation

HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 3 Feb 2010
Medco Acquires Leading Genetics Healthcare Company, DNA Direct
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 19 Jan 2010
QuantRx CEO Provides Update on Genetics-based Personalized Medicine and Disease Prevention Platform Technology
Diagnostics Personalized Medicine

HSMN NewsFeed - 18 Jan 2010
HolGenTech to Demo Genome Based Prevention Model in Hand-Held Personal Genome Assistant at Personalized Medicine World Conference
Personalized Medicine

HSMN NewsFeed - 13 Jan 2010
AstraZenenca and CrystalGenomics, Inc. Form Research Collaboration to Develop Novel Anti-Infective Treatments
Biopharmaceuticals

HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 11 Jan 2010
Viamet Pharmaceuticals Names William Moore, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Dec 2009
David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
Personalized Medicine Personnel

HSMN NewsFeed - 17 Dec 2009
DNA Direct Receives URAC Accreditation for Health Utilization Management
Diagnostics

HSMN NewsFeed - 17 Dec 2009
FDA Broadens Clearance for Agendia's MammaPrint(R)
Diagnostics Oncology FDA

HSMN NewsFeed - 9 Dec 2009
Oxford BioTherapeutics Appoints Michael Moore as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2009
NeoGenomics Announces Executive Appointments
Diagnostics Oncology Personnel

HSMN NewsFeed - 23 Nov 2009
ARCA Receives FDA Fast Track Designation for Gencaro(TM) Development in Genotype-Defined Heart Failure Population
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 17 Nov 2009
XOMA Appoints Jim Neal Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2009
Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2009
Biocartis Raises EUR10 Million in Series A Financing Round
Diagnostics Venture Capital

HSMN NewsFeed - 22 Sep 2009
Agendia Raises US $23 Million in Series E Financing
Diagnostics Venture Capital

HSMN NewsFeed - 21 Sep 2009
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2009
Luminex Receives 510(K) Clearance for New Cystic Fibrosis Test
Diagnostics FDA

HSMN NewsFeed - 24 Jul 2009
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
Diagnostics Oncology

HSMN NewsFeed - 20 Jul 2009
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Jul 2009
Benjamin L. Palleiko Named Chief Financial Officer of Ore Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2009
Nuon Therapeutics Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2009
Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 19 May 2009
Molecular Diagnostics Company, RedPath, Appoints Dennis M. Smith, Jr., M.D. as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 May 2009
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Diagnostics Neurology

HSMN NewsFeed - 13 Apr 2009
Molecular Diagnostics Company, RedPath, Appoints Mark D. Myslinski as Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 17 Mar 2009
Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Mar 2009
Mark J. Gabrielson Named Chief Executive Officer of Ore Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Feb 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 17 Feb 2009
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 5 Feb 2009
Cytomedix Further Strengthens Its Board of Directors
Devices Wound Care Personnel

HSMN NewsFeed - 4 Feb 2009
Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
Diagnostics Oncology

HSMN NewsFeed - 20 Jan 2009
Luminex Corporation Announces Organizational Change
Diagnostics Personnel

HSMN NewsFeed - 8 Jan 2009
Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
Venture Capital Personnel

HSMN NewsFeed - 8 Jan 2009
Agendia Appoints New Chief Financial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 4 Dec 2008
NovaRx Appoints Industry Veteran as President and COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2008
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
Diagnostics Personnel

HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2008
Tekmira Pharmaceuticals Expands Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2008
Noven Names Peter Amanatides as Vice President - Quality Assurance & Quality Control
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2008
Invitrogen, Biocare to Market FDA Approved Breast Cancer Test
Diagnostics FDA

HSMN NewsFeed - 11 Sep 2008
Seigo Izumo, MD Joins Gilead as Senior Vice President, Cardiovascular Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2008
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Aug 2008
Pharmacogenomics Pioneer HairDX Names David Teckman President and CEO
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 8 Aug 2008
Roche's 454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome, Establishing When Humans and Neanderthals Diverged
Diagnostics

HSMN NewsFeed - 8 Aug 2008
EXACT Sciences Announces Next Generation Stool-based DNA Technology Study Results of 92% for Colorectal Cancer Detection
Diagnostics Gastroenterology Oncology

HSMN NewsFeed - 31 Jul 2008
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Diagnostics Oncology FDA

HSMN NewsFeed - 29 Jul 2008
The DNA Repair Company Strengthens Operations and Development Capabilities with Addition of Two Senior Officials
Oncology Personnel

HSMN NewsFeed - 15 Jul 2008
Collegium Pharmaceutical Announces Completion of Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jul 2008
Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
Diagnostics

HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Jun 2008
Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility
Diagnostics FDA

HSMN NewsFeed - 14 May 2008
Major Sudden Cardiac Arrest Risk Stratification Trials Unveiled
Devices Cardiology

HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2008
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
Diagnostics FDA

HSMN NewsFeed - 21 Apr 2008
Power3 Medical Products Issues Letter to Shareholders
Diagnostics

HSMN NewsFeed - 18 Apr 2008
Genomics Likely to Replace Traditional Drug Therapies in Treating CHF
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Apr 2008
John D. Baxter, M.D. Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2008
Ipsen: Appointment of Dominique Bridon, PhD as Vice President, Discovery
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2008
Medivation Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Mar 2008
Clinical Data, Inc. Initiates Second Pivotal Phase III Study of Vilazodone
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2008
Colorectal Cancer Screening Guidelines Released by the American Cancer Society Include EXACT Sciences' Stool DNA Technology
Diagnostics Oncology

HSMN NewsFeed - 4 Mar 2008
Luminex Announces Executive Management Changes
Diagnostics Personnel

HSMN NewsFeed - 28 Feb 2008
Luminex and Abbott Sign Agreement for Global Distribution of the xTAG(TM) Respiratory Viral Panel
Diagnostics Distribution

HSMN NewsFeed - 20 Feb 2008
Luminex Corporation Places 5,000th Instrument
Diagnostics

HSMN NewsFeed - 19 Feb 2008
Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
Diagnostics Oncology Licensing

HSMN NewsFeed - 14 Feb 2008
QuantRx(R) Biomedical Announces Second Agreement With ALT BioScience to Develop Diagnostic Tests for Oral Health
Diagnostics

HSMN NewsFeed - 5 Feb 2008
Clinical Data's FAMILION Test Meets Criteria for Diagnosis of Long QT Syndrome Set By Blue Cross and Blue Shield Association Technology Evaluation Center
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 23 Jan 2008
Ampersand Ventures Invests in Signature Genomic Laboratories
Diagnostics Venture Capital

HSMN NewsFeed - 22 Jan 2008
Progentix Orthobiology B.V. Closes Series A Financing Round
Regenerative Medicine Venture Capital

HSMN NewsFeed - 20 Jan 2008
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
Devices Personnel

HSMN NewsFeed - 18 Jan 2008
EXACT Sciences Schedules Meeting with CMS to Discuss Application for National Coverage of Stool-based DNA Colorectal Cancer Screening
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital

HSMN NewsFeed - 10 Jan 2008
Idera Pharmaceuticals Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2008
Genizon BioSciences Secures $31 Million in Additional Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Jan 2008
Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel
Diagnostics FDA

HSMN NewsFeed - 17 Dec 2007
LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
Devices Personnel

HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Nov 2007
Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
Diagnostics Personnel

HSMN NewsFeed - 30 Oct 2007
Gene Logic Selects New Company Name: Ore Pharmaceuticals Inc.
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 25 Oct 2007
QuantRx Biomedical Corporation Announces FDA 510(k) Clearance for Its Follicle Stimulating Hormone (FSH) Immunoassay Test
Diagnostics FDA

HSMN NewsFeed - 23 Oct 2007
Celera Completes Acquisition of Atria Genetics, Inc.
Diagnostics Acquisitions

HSMN NewsFeed - 16 Oct 2007
Linkage Biosciences Completes Seed Financing
Diagnostics Venture Capital

HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 15 Oct 2007
Celera Completes Acquisition of Berkeley HeartLab, Inc.
Diagnostics Mergers & Acquisitions Cardiology

HSMN NewsFeed - 11 Oct 2007
Access Genetics Announces New Executive Appointments
Diagnostics Personnel

HSMN NewsFeed - 10 Oct 2007
Transgenomic Names New Sr. VP of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 4 Oct 2007
Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 3 Oct 2007
Alethia Biotherapeutics Inc. Announces in-Licensing of Family of Monoclonal Antibodies to Treat Metastatic Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 25 Sep 2007
CombiMatrix Molecular Diagnostics Launches HemeScan MDS for the Management and Diagnosis of Myelodysplastic Syndromes
Diagnostics Oncology

HSMN NewsFeed - 24 Sep 2007
GenomeQuest, Inc. Announces $4 Million in New Venture Funding to Bolster Enterprise Offering
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Sep 2007
Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
ImaRx Therapeutics Names Richard L. Love as Chairman and Announces Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
Celera to Acquire Atria Genetics
Diagnostics Acquisitions

HSMN NewsFeed - 17 Sep 2007
EraGen Announces Appointment of Blanc as Vice President, Corporate Development
Diagnostics Personnel

HSMN NewsFeed - 5 Sep 2007
The Molecular Profiling Institute Launches Mammostrat(TM) - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 4 Sep 2007
Celera to Acquire Berkeley HeartLab, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 Aug 2007
Entelos Acquires Iconix Biosciences, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Aug 2007
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
Diagnostics Mergers & Acquisitions Personnel

HSMN NewsFeed - 9 Aug 2007
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2007
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
Biopharmaceuticals Mergers & Acquisitions Oncology

HSMN NewsFeed - 11 Jul 2007
EXACT Sciences' DNA Technology is Preferred Non-Invasive Method for Colorectal Cancer Screening Among Patients
Diagnostics Oncology

HSMN NewsFeed - 4 Jul 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jul 2007
ZymoGenetics Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2007
Renovis Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Dmitry Samarsky, Ph.D., as Vice President of Technology Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2007
CombiMatrix Molecular Diagnostics Launches HemeScan(TM) Ploidy Test for the Management of Acute Lymphoblastic Leukemia
Diagnostics Oncology

HSMN NewsFeed - 21 Jun 2007
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Diagnostics Regulatory

HSMN NewsFeed - 18 Jun 2007
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
Diagnostics Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Jun 2007
Anacor Names Paulette Dillon as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2007
Dr. Patrice Milos Joins Helicos BioSciences as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2007
EXACT Sciences and NorDiag Announce International Collaboration and License Agreement for Colorectal Cancer
Diagnostics Oncology Licensing

HSMN NewsFeed - 22 May 2007
CytRx Names Shi Chung Ng, Ph.D., Senior Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2007
Pathwork Diagnostics Expands Executive Team
Diagnostics Oncology Personnel

HSMN NewsFeed - 10 May 2007
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2007
Gene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug Candidates
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 May 2007
Bristol-Myers Squibb Joins Oslo Cancer Cluster
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Diagnostics Oncology Licensing

HSMN NewsFeed - 24 Apr 2007
Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
Diagnostics Licensing

HSMN NewsFeed - 19 Apr 2007
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after Receiving CLIA High-Complexity Certification
Diagnostics Personnel

HSMN NewsFeed - 19 Apr 2007
QuantRx(R) Biomedical Acquires Majority Interest in FluoroPharma
Diagnostics Cardiology

HSMN NewsFeed - 18 Apr 2007
Thallion Presents Data at the 2007 Annual Meeting of the American Association of Cancer Research on its Oncology Drug Candidates ECO-4601 and CAP-232
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Apr 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Apr 2007
Gene Logic Board Elects Two New Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Apr 2007
Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Mar 2007
Gene Logic Names New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board for Respiratory and Acute Care Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2007
Calistoga Pharmaceuticals, A Newly Formed Drug Development Company, Announces Its Formation and Completion of a $21 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Feb 2007
Schering-Plough Announces Executive Changes in Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2007
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 22 Feb 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 22 Feb 2007
Dr. Mansoor Mohammed Appointed CEO of CombiMatrix Molecular Diagnostics
Diagnostics Personnel

HSMN NewsFeed - 21 Feb 2007
Pharmacyclics Receives Refuse to File Letter for Xcytrin
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Feb 2007
PDL BioPharma Announces New Chief Medical Officer and Appoints Chief Scientific Officer to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2007
Clinical Data Supporting Development of ChemGenex's Ceflatonin(R) in Imatinib-Resistant CML Published in Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Feb 2007
ARIAD Grants Second Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 30 Jan 2007
Metabolon Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2007
Cangene hires new Vice President of R&D
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2007
Scientists Discover New Gene Associated with Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 Jan 2007
Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome
Diagnostics Licensing

HSMN NewsFeed - 16 Jan 2007
Stan Fronczkowski to Join Strategic Diagnostics as Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 9 Jan 2007
NeoGenomics, Inc. Announces the Appointment of Robert J. Feeney, Ph.D. as Vice President of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 8 Jan 2007
Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
Diagnostics Regulatory

HSMN NewsFeed - 3 Jan 2007
Luminex Signs Agreement With Fisher HealthCare
Diagnostics

HSMN NewsFeed - 2 Jan 2007
Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Dec 2006
The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Dec 2006
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Dec 2006
FDA Approves Orphan Drug Designation for SIGA's Smallpox Drug, SIGA-246
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2006
Adolor Elects Michael R. Dougherty Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2006
DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating Anemia
Biopharmaceuticals

HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Nov 2006
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Nov 2006
Bristol-Myers Squibb Company Announces Promotion of Andrew Bonfield and Elliott Sigal to Executive Vice Presidents
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2006
CombiMatrix Molecular Diagnostics Announces the Launch of Powerful New Melanoma Test
Diagnostics

HSMN NewsFeed - 1 Nov 2006
Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
Diagnostics Personnel

HSMN NewsFeed - 23 Oct 2006
Luminex Corporation Announces Market Release of Pneumococcal Assay
Diagnostics

HSMN NewsFeed - 23 Oct 2006
ChondroGene announces name change to GeneNews
Diagnostics

HSMN NewsFeed - 20 Oct 2006
Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Oct 2006
EXACT Sciences Corporation Announces Restructuring and Third Quarter 2006 Conference Call
Diagnostics

HSMN NewsFeed - 11 Oct 2006
ARIAD Grants Commercial License to Its Patented ARGENT(TM) Cell-Signaling Regulation Technology for Development of New Cancer Therapies
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Oct 2006
Specialty Laboratories Launches First Genomic Clinical Laboratory Test to Predict Progression to Liver Fibrosis for Hepatitis C Virus Patients
Diagnostics

HSMN NewsFeed - 28 Sep 2006
Celera Identifies FCAR Genetic Polymorphism Associated with Increased Risk for Myocardial Infarction
Cardiology

HSMN NewsFeed - 26 Sep 2006
deCODE Files Suit to Defend Intellectual Property
Biopharmaceuticals Personnel Litigation

HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2006
Greenwood Releases Statement on IOM Drug Safety Document
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2006
QuantRx(R) Biomedical Appoints Former FDA Commissioner Dr. Arthur Hull Hayes, Jr. to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 12 Sep 2006
Cylex's Immune Function Test, ImmuKnow(R), Identifies Optimal Immune Status for Post-Transplant Therapy and Guides Physicians to Minimize Risk of Infection and Rejection
Diagnostics

HSMN NewsFeed - 12 Jul 2006
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2006
CombiMatrix Molecular Diagnostics to Offer First Commercial Genetic Test from Its CLIA Certified Laboratory
Diagnostics

HSMN NewsFeed - 23 Jun 2006
Poniard Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2006
Clinical Data Announces Management Reorganization and Plan to Spin Off Vilazodone Business
Biopharmaceuticals

HSMN NewsFeed - 10 May 2006
ChondroGene appoints David Tyler Director, Product Development and Quality Assurance
Diagnostics Personnel

Return to NewsFeed

Additional items found! 458

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 458 additional stories matching:
genomics
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.